SU465815A1 - Medicinal agent - Google Patents

Medicinal agent Download PDF

Info

Publication number
SU465815A1
SU465815A1 SU681233438A SU1233438A SU465815A1 SU 465815 A1 SU465815 A1 SU 465815A1 SU 681233438 A SU681233438 A SU 681233438A SU 1233438 A SU1233438 A SU 1233438A SU 465815 A1 SU465815 A1 SU 465815A1
Authority
SU
USSR - Soviet Union
Prior art keywords
april
treatment
medicinal agent
compound
base
Prior art date
Application number
SU681233438A
Other languages
Russian (ru)
Inventor
Г.Н. Першин
Н.С. Богданова
И.С. Николаева
М.Я. Крафт
Г.М. Бородина
Е.Н. Сытина
Original Assignee
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе filed Critical Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе
Priority to SU681233438A priority Critical patent/SU465815A1/en
Priority to DE19691917981 priority patent/DE1917981A1/en
Priority to GB1225584D priority patent/GB1225584A/en
Priority to FR6912119A priority patent/FR2007474A1/fr
Application granted granted Critical
Publication of SU465815A1 publication Critical patent/SU465815A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,225,584. Antiviral compositions. VSESOJUZNY NAUCHNO-ISSLEDOVATELSKY KHIMIKO - FARMATSEVTICHESKY INSTITUT IMENI S. ORDZHONIKIDZE. 15 April, 1969 [18 April, 1968], No. 19109/69. Heading A5B Pharmaceutical compositions for combating virus infections comprise an ointment base and the compound 3,5,3',5'-tetrabromo-2,4,2',4'- tetrahydroxy diphenyl. Ointments are disclosed comprising 0.1, 0.25 and 1% by weight of the active compound in a soft paraffin/liquid paraffin base.

Description

.«. "

3535

елate

эоeo

:л 1 Насто щее изобретение относитс  области медицины, точнее к лекарственным препаратам дл  лечени  вирус ных . заболеваний глаз. Используемый дл  лечени  указанных заболеваний препарат керацид (5-йод-2-дезоксиуридин) обладает слабым терапевтическим действием и не всегда дает необходимый эффект. В частности, он не приводит к положительным результатам при лечении аденовирусных кератоконъюктивитов. Предлагаемое лекарственное средство , 3,5,3,5 -тетрабром-2,4,2,4тетраоксидифенил (теброфен), рекоме дуетс  примен ть дл  лечени  вирусных заболеваний глаз. Лечение осуществл ют 0,1-1,0%-ны ми теброфеновыми маз ми, заклады2 ваемыми в конъюктивальный мешок 34 раза в день до получени  терапевтического эффекта. В случае сопутствующей бактериальной инфекции конъюктивы протибовирусное лечение может быть дополнено применением антибактериальных препаратов. При глубоких кератитах нар ду с теброфейовой мазью можно использовать гамма-глобулин, перивазальные новокаиновые блокады, криотерапию и витамины. Дл  лечени  . лиша  (простого первичного и рецидивирзтощего опо сьгоающего) , дерматоза Дюринга, чешуйчатого лиша  рекомендуетс  1%-на  мазь, накладываема  на пораженные участки кожи 23 раза в день до излечени .: l 1 The present invention relates to the field of medicine, more specifically to drugs for the treatment of viral. eye diseases. The drug keracid (5-iodine-2-deoxyuridine) used to treat these diseases has a weak therapeutic effect and does not always give the desired effect. In particular, it does not lead to positive results in the treatment of adenoviral keratoconjunctivitis. The proposed drug, 3,5,3,5-tetrabrom-2,4,2,4 tetraoxydiphenyl (tebrofen), is recommended for the treatment of viral eye diseases. The treatment is carried out with 0.1-1.0% tebrofen ointments, placed in the conjunctival bag 34 times a day to obtain a therapeutic effect. In the case of a concomitant bacterial infection of the conjunctiva, the anti-viral treatment can be supplemented by the use of antibacterial drugs. For deep keratitis, gamma globulin, perivasal novocaine blockades, cryotherapy, and vitamins can be used along with a toprophic ointment. For treatment. Lichen (simple primary and recurrent nursing regimen), Düring dermatosis, scaly lish is recommended 1% ointment applied to the affected skin 23 times a day until cure.

Claims (2)

ЛЕКАРСТВЕННОЕ СРЕДСТВО Применение 3,5,3',5 -тетрабром-2, 4-2* ,4'-тетраоксвдифенила (теброфена) в качестве средства для лечения вирусных заболеваний глаз.MEDICINE Use of 3,5,3 ', 5-tetrabrom-2, 4-2 *, 4'-tetraoxvdiphenyl (tebrofen) as a treatment for viral diseases of the eyes. «и"and эоeo 11 465815465815 22 НастоящееThe present
SU681233438A 1968-04-18 1968-04-18 Medicinal agent SU465815A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SU681233438A SU465815A1 (en) 1968-04-18 1968-04-18 Medicinal agent
DE19691917981 DE1917981A1 (en) 1968-04-18 1969-04-09 Medicines for the treatment of diseases of viral etiology
GB1225584D GB1225584A (en) 1968-04-18 1969-04-15
FR6912119A FR2007474A1 (en) 1968-04-18 1969-04-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU681233438A SU465815A1 (en) 1968-04-18 1968-04-18 Medicinal agent

Publications (1)

Publication Number Publication Date
SU465815A1 true SU465815A1 (en) 1987-03-23

Family

ID=20442281

Family Applications (1)

Application Number Title Priority Date Filing Date
SU681233438A SU465815A1 (en) 1968-04-18 1968-04-18 Medicinal agent

Country Status (4)

Country Link
DE (1) DE1917981A1 (en)
FR (1) FR2007474A1 (en)
GB (1) GB1225584A (en)
SU (1) SU465815A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140732B (en) * 1965-05-04 1974-01-15 Acf Chemiefarma Nv PROCEDURE FOR PREPARING MEDICINAL PRODUCTS WITH ANTIPARASITARY ACTION AND ACTIVE INGREDIENTS THEREOF, AND THE PRODUCTS OBTAINED THEREOF.

Also Published As

Publication number Publication date
DE1917981A1 (en) 1969-12-04
FR2007474A1 (en) 1970-01-09
GB1225584A (en) 1971-03-17

Similar Documents

Publication Publication Date Title
Mukoyama et al. Aspergillosis of the central nervous system: report of a brain abscess due to A. fumigatus and review of the literature
Farnsworth Metabolic changes associated with administration of adrenocorticotropin in the nephrotic syndrome.
RU2017132877A (en) COMBINATION OF PD-1 ANTAGONIST AND ERIBULIN FOR CANCER TREATMENT
SU465815A1 (en) Medicinal agent
Bershof et al. AGRANULOCYTOSIS FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN9): REPORT OF A CASE
Gabriel et al. Reversible encephalopathy and acute renal failure after cephaloridine.
Cherubini et al. Anterior Nongranulomatous Uveitis Associated With Rocky Mountain Spotted Fever: First Report of a Case
Gyde et al. Gangrene of digits after chicken-pox.
Barnes et al. Oral treatment of Trichomonas vaginitis with aminitrozole
Medina et al. Haemophilus influenza type b orbital cellulitis.
JPH06340549A (en) Therapeutic agent for feline respiratory organ disease and therapeutic method using the therapeutic agent
RU2005136271A (en) METHOD FOR DIAGNOSTIC AND TREATMENT OF NEUROLOGICAL DAMAGE IN CHILDREN OF EARLY AGE
Bliss et al. Effect of Sulfapyridine, Sulfathiazole and Sulfamethylthiazole upon Severe Staphylococcal Infection in Mice.
US10080761B2 (en) Method for treating recurring skin and mucous membrane diseases caused by HSV-1 and HSV-2
SU1685454A1 (en) Burn treatment agent "xymedon"
SULTAN et al. Sulfonamide compounds and penicillin: the effect of combined therapy on experimental infections in mice
US4230725A (en) Antiviral agent
FOSTER et al. THE TREATMENT OF ACUTE TYPHOID FEVER WITH CHLOROMYCETIN®
Katz et al. A study of parenteral oxytetracycline and tetracycline
LidaMantle Emla Cream (B) 5, 30 gm/tube
SU917839A1 (en) Method of treating psoriasis
RU2014082C1 (en) Antitumoral agent
SU552085A1 (en) Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis
RU2613187C1 (en) Method of treating hyperkinetic syndrome in patients in vegetative state and minimally conscious state
Gjessing et al. Intramuscular injection of procaine penicillin combined with oral administration of ampicillin in the treatment of gonorrhoea